Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
This study is designed to evaluate the safety and efficacy of adjuvant FOLFIRINOX regimen in pancreatic cancer patients after curative surgery.
Adjuvant Chemotherapy
Disease-free survival, Duration of survival before pancreatic cancer recurrence or death, Day 1 to Week 88
Overall survival, Duration of overall survival, Day 1 to Week 88
This study is multi-center, prospective, long-term follow-up observational study.